Urolithin A is a compound produced when gut bacteria metabolize ellagitannins, polyphenols found in pomegranates, walnuts, and certain berries. Its primary mechanism of interest is mitophagy activation—the cellular process of identifying and clearing damaged mitochondria so they can be replaced by healthier ones. This quality-control system tends to decline with age, and its restoration has shown measurable effects on muscle and cardiovascular health markers in early human studies [1].
As interest has grown, so has the supplement market—and not always with careful quality control. A 2024 laboratory analysis found notable discrepancies between the urolithin A amounts stated on product labels and the amounts actually present in tested supplements [4]. Understanding what to look for—and what questions to ask—can help you make a more informed decision than brand marketing alone allows.
Key Takeaways
- Not everyone can produce urolithin A from food; direct supplementation bypasses the need for specific gut bacteria [7].
- Label accuracy is a documented problem in the UA supplement category—independent third-party certificates of analysis are essential [4].
- Human safety and mechanistic data exist primarily for doses of 500–1000 mg per day; products with substantially lower doses have weaker scientific grounding [1].
- Liposomal and nanoparticle delivery formats may improve bioavailability over free-form UA, though most commercial products still use standard crystalline forms [3].
- Early evidence for mitochondrial, muscle, and cardiovascular health benefits is promising but preliminary—no UA product has been approved to treat or prevent disease [6].
What Urolithin A Does and Why Diet Alone May Not Be Enough
Urolithin A is not found directly in food. It is a postbiotic—a compound your intestinal microbiome synthesizes after processing ellagitannins from foods like pomegranate, walnuts, and raspberries [2]. The conversion requires specific bacterial strains, and research consistently shows that a significant portion of the adult population lacks the gut microbiome profile necessary to produce meaningful quantities of UA from diet alone [7].
This is the practical rationale for direct supplementation. If you cannot reliably produce UA yourself, eating more pomegranate seeds does not reliably raise circulating UA levels. Supplementing with pre-formed UA bypasses the microbial conversion step entirely. The tradeoff is that you are now dependent on the supplement actually containing what it claims—which, as discussed below, is not guaranteed.
The Mitophagy Mechanism: What the Science Actually Says
Mitochondria accumulate damage over time from oxidative stress and normal metabolic activity. Cells have a recycling system called mitophagy that tags and removes defective mitochondria; when this process is running well, it supports energy production, reduces cellular stress, and may slow aspects of age-related functional decline [5]. Urolithin A has been identified as one of the more studied natural activators of this pathway.
A controlled human study found that supplementation with UA produced a molecular signature consistent with improved mitochondrial and cellular health, including changes in gene expression related to mitochondrial biogenesis and mitophagy, compared to placebo [1]. Cardiovascular biomarker data from a 2025 study suggested potential benefits for heart muscle mitochondrial quality as well [6]. These findings are early-stage; they establish biological plausibility and measurable changes in biomarkers, but do not yet prove prevention or treatment of specific diseases.
The Label Accuracy Problem: A Real Reason for Scrutiny
One of the clearest reasons to scrutinize a UA supplement before purchasing it is label accuracy. A 2024 analysis that tested the actual content of urolithin A products against their stated label claims found that many products did not match what was printed on the bottle [4]. Some contained significantly less active compound than labeled; others varied substantially across lots.
This is not a minor issue. If the effective dose explored in human studies is 500 mg per day and the supplement you are taking contains only a fraction of that amount, you are unlikely to experience the same biological effects. Choosing brands that publish independent third-party certificates of analysis from accredited laboratories is one of the few practical ways a consumer can verify label accuracy before purchase. A company’s own internal testing is not a substitute.
Bioavailability and Formulation: Why Delivery Method Matters
Even when a supplement contains the correct amount of urolithin A, how well your body absorbs it matters. UA is a relatively lipophilic compound, and standard powder or capsule forms may have limited oral bioavailability. Research has explored encapsulation technologies to address this. A comparative study on liposome-encapsulated UA found that this delivery format significantly improved the compound’s stability, bioaccessibility, and bioavailability compared to free-form UA [3].
Newer nanoparticle formulations have shown similar advantages in preclinical models [8], though these remain largely in research settings rather than widely available commercial supplements. For consumers, a practical question is whether a product uses any validated delivery technology—and whether the company can point to data supporting that choice rather than simply using phrases like ‘enhanced absorption’ without evidence.
Crystalline or spray-dried forms of UA are the most common in commercial products today. These have been studied at the preclinical and early clinical level [1], and direct UA supplementation sidesteps the microbiome conversion issue entirely. The key is verifying that the chosen form is present in adequate quantities and that the manufacturer has performed stability testing to confirm potency over the product’s shelf life.
Dosing: What Human Studies Have Used as Reference Points
The most referenced human clinical data on urolithin A used doses of 250 mg, 500 mg, and 1000 mg per day, with the 500 mg and 1000 mg doses showing the most consistent molecular signals of mitochondrial benefit [1]. This gives you a practical benchmark: products offering far lower doses per serving than these study doses have weaker scientific grounding, even if the ingredients are otherwise genuine.
It is also worth noting that UA research has focused primarily on middle-aged to older adults. Most mechanistic and safety work has not been conducted across the full range of ages or health conditions. The safety profile observed in the published human trial was favorable, with no serious adverse events reported at doses up to 1000 mg per day [1], but this does not mean every person will respond identically, and longer-term high-dose data remain limited.
A Practical Checklist for Evaluating Any Urolithin A Supplement
Given what the research shows, here is a framework for assessing a UA product. First, verify the ingredient: the label should list urolithin A by that name, not just ‘pomegranate extract,’ which may contain only ellagitannin precursors and cannot guarantee UA delivery in individuals whose microbiomes lack the converting bacteria [2]. Second, require third-party testing. Look for a certificate of analysis from an independent accredited lab, given the documented label accuracy problems in this supplement category [4].
Third, assess the dose against published human study benchmarks. Products supplying meaningfully less than 500 mg per serving have limited clinical literature behind them [1]. Fourth, ask about formulation. Whether a company uses standard crystalline UA, a liposomal system, or another delivery format, they should be able to explain the rationale and ideally point to data supporting absorption claims [3]. Fifth, treat any disease or anti-aging guarantee as a red flag. UA research is ongoing and promising, but no urolithin A supplement is approved to treat, cure, or prevent any medical condition.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day — The clinically studied form (Amazentis); used in the human trials. - DoNotAge Pure Urolithin A
capsules, 250-500 mg — Popular longevity-brand generic, third-party tested. - ProHealth Longevity Urolithin A
capsules, 500 mg — Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg — Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
Urolithin A supplements are not approved to diagnose, treat, cure, or prevent any medical condition, and long-term safety data in humans across diverse populations remain limited. People who are pregnant, nursing, taking prescription medications, or managing chronic health conditions should consult a qualified healthcare provider before starting urolithin A or any new supplement.
Frequently Asked Questions
Can I get enough urolithin A from eating pomegranates or other foods?
Only if your gut microbiome contains the bacteria needed to convert ellagitannins into UA—and research shows a meaningful proportion of adults lack these strains [7]. For those without the right microbial profile, eating a pomegranate-rich diet may not meaningfully raise circulating UA levels. This is the core scientific rationale for pre-formed UA supplements.
What dose of urolithin A has been used in human studies?
A published clinical trial tested doses of 250 mg, 500 mg, and 1000 mg per day, with the higher two doses producing the most consistent evidence of mitochondrial gene expression changes [1]. Products falling significantly below these doses have less clinical reference to support their efficacy claims.
Are urolithin A supplements accurately labeled?
Not always. A 2024 analysis testing UA and related supplement products found discrepancies between stated label amounts and actual measured content [4]. This makes third-party verified certificates of analysis an important quality signal when choosing a product, rather than relying solely on what the label states.
Does the form of urolithin A—liposomal versus standard—make a difference?
Research comparing liposome-encapsulated UA to free-form UA found the liposomal format improved stability, bioaccessibility, and bioavailability in a controlled study [3]. Whether this difference produces meaningfully different clinical outcomes at typical commercial doses has not been definitively established. Standard crystalline forms used in the main safety and efficacy human trial also showed measurable biological effects [1].
Is urolithin A safe to take?
A human clinical trial reported no serious adverse events at doses up to 1000 mg per day and described UA as safe with a molecular signature of improved mitochondrial and cellular health [1]. However, this was a relatively short-term controlled study, and long-term safety data in diverse populations are still limited. People with medical conditions or who take prescription medications should consult a healthcare provider before adding any new supplement.
What health benefits does the current research actually support?
Early human and preclinical evidence points to improvements in mitochondrial quality markers [1], support for muscle health pathways associated with mitophagy [5], and changes in cardiovascular health biomarkers [6]. These findings are biologically meaningful but preliminary. UA is not approved to treat any disease, and effects on hard clinical endpoints—such as muscle strength outcomes, cardiovascular events, or lifespan—remain under active investigation.
References
- Andreux PA et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature metabolism (2019). PMID 32694802
- Zhang M et al. Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation. Critical reviews in food science and nutrition (2023). PMID 35142569
- Hu Y et al. Liposomes encapsulation by pH driven improves the stability, bioaccessibility and bioavailability of urolithin A: A comparative study. International journal of biological macromolecules (2023). PMID 37865359
- Sandalova E et al. Testing the amount of nicotinamide mononucleotide and urolithin A as compared to the label claim. GeroScience (2024). PMID 38935229
- Broome SC et al. Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing. Sports medicine (Auckland, N.Z.) (2024). PMID 39060742
- Liu S et al. Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers. iScience (2025). PMID 40034121
- Yuan H et al. Urolithin A From Gut Metabolite to Therapeutic Agent: Bioavailability, Mechanisms, and Translational Insights. Journal of food science (2026). PMID 41866331
- Zhang L et al. Gum arabic-coated urolithin A liposome nanoparticles: Fabrication, characterization, bioavailability and improved alleviation on NAFLD activity in vivo. Carbohydrate polymers (2026). PMID 42097775
